North America

The New Patented Medicines (Notice of Compliance) Regulations and Certificate of Supplementary Protection Regulations

By Marie Lafleur, Fasken Martineau

The Comprehensive Economic and Trade Agreement (CETA) was signed by Canada and the European Union (EU) on October 30, 2016. The following day, the Canadian Government introduced legislation to amend Canadian laws for the purpose of bringing consistency between Canadian and European Union intellectual property laws and regulations …

Read more, download or share the PDF update below ..

Tags: Canada, European Union, Intellectual Property, Life Sciences
Latest Updates
Related Articles
Related Articles by Jurisdiction
Health Canada pushes for safer medical devices
The announcements foreshadow significant near-term changes to Canada's medical device regulatory regime.
Energy Licences and Approvals in Canada
Update on Directive 067: Eligibility Requirements for Acquiring and Holding Energy Licences and Approvals ...
A change of role for a legal representative under the new Clinical Trials Regulation 536/2014?
The roles and responsibilities of the legal representative set out under Clinical Trials Directive 2001/20/EC are likely to change under the new Clinical Trials Regulation 536/2014.
Latest Articles